Conference
268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101)
| العنوان: | 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101) |
|---|---|
| المؤلفون: | Berton-Rigaud, Dominique, Vergote, Ignace, Pautier, Patricia, Kryzhanivska, Anna, Angelergues, Antoine, Kornacki, Deanna, Dudzisz-Sledz, Monika, Tian, Chuan, Bourayou, Nawel, Selle, Frederic |
| المصدر: | Regular and young investigator award abstracts ; page A164.2-A165 |
| بيانات النشر: | BMJ Publishing Group Ltd |
| سنة النشر: | 2020 |
| نوع الوثيقة: | conference object |
| اللغة: | unknown |
| DOI: | 10.1136/jitc-2020-sitc2020.0268 |
| DOI: | 10.1136/jitc-2020-SITC2020.0268 |
| الاتاحة: | http://dx.doi.org/10.1136/jitc-2020-sitc2020.0268 https://syndication.highwire.org/content/doi/10.1136/jitc-2020-SITC2020.0268 |
| Rights: | http://creativecommons.org/licenses/by-nc/4.0/ |
| رقم الانضمام: | edsbas.D3B369C4 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/jitc-2020-sitc2020.0268 |
|---|